Literature DB >> 1570155

Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains.

M Wick1, F C Lucibello, R Müller.   

Abstract

We show that transformation-defective Fos proteins lacking either a functional leucine zipper (mutants L345 and J/R510s) or the 110 amino-terminal amino acids (mutant BR800) inhibit the induction of morphological transformation by v-Fos. Both types of mutants specifically repress transformation without any significant effect on cell proliferation. In contrast, several transformation-defective Fos mutants with structural alterations in the acidic region or the right half of the adjacent basic DNA contact site do not show any inhibition of transformation. This result, taken together with the repression of transformation by the leucine zipper-deficient mutants L345 and J/R510s, indicates that the interaction of Fos with proteins other than Jun is necessary for transformation. The leucine zipper-deficient mutants also inhibit Fos-mediated activation of AP-1-dependent transcription. This suggests that their inhibitory effect on transformation may at least in part be the result of the squelching of proteins other than Jun family members that are required for Fos-mediated transactivation. All three mutants were also found to inhibit transformation by the point-mutated H-ras oncogene from EJ carcinoma cells and to trigger a partial reversion of the transformed phenotype of Ras-transformed fibroblasts. These findings support the conclusion that Ras-induced transformation involves signal transduction pathways inducing the c-fos gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570155

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity.

Authors:  Pradeep D Uchil; Angelika Hinz; Steven Siegel; Anna Coenen-Stass; Thomas Pertel; Jeremy Luban; Walther Mothes
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

2.  Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF.

Authors:  M L Martin; P M Lieberman; T Curran
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1.

Authors:  M C Frame; K Simpson; V J Fincham; D H Crouch
Journal:  Mol Biol Cell       Date:  1994-11       Impact factor: 4.138

4.  A novel, transformation-relevant activation domain in Fos proteins.

Authors:  M Funk; B Poensgen; W Graulich; V Jerome; R Müller
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.

Authors:  Paula Monje; Maria Julia Marinissen; J Silvio Gutkind
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

6.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Analysis of AP-1 function in cellular transformation pathways.

Authors:  T Suzuki; M Murakami; N Onai; E Fukuda; Y Hashimoto; M H Sonobe; T Kameda; M Ichinose; K Miki; H Iba
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 8.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

9.  Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.

Authors:  G G Miao; T Curran
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.

Authors:  K L Hawker; A Pintzas; R F Hennigan; D A Gillespie; B W Ozanne
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.